Two Sigma Securities’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SFCM
Two Sigma Securities's MTRI Position: Q3 2026 in Review
Two Sigma Securities sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2026, closing a stake of 1,095 shares — an estimated $17K sold.
Two Sigma Securities first reported a position in MTRI in Q1 2022 and held it in 5 quarters. The position peaked at $17K in Q1 2022. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.
- Two Sigma Securities reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2026 after selling out during the quarter.
- Two Sigma Securities sold 1,095 Mentari Therapeutics, Inc. Common Stock shares in Q3 2026, an estimated $17K.
- Two Sigma Securities first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
- Two Sigma Securities's Mentari Therapeutics, Inc. Common Stock position peaked at $17K in Q1 2022.
- 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.